BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17041886)

  • 41. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
    Belov L; Mulligan SP; Barber N; Woolfson A; Scott M; Stoner K; Chrisp JS; Sewell WA; Bradstock KF; Bendall L; Pascovici DS; Thomas M; Erber W; Huang P; Sartor M; Young GA; Wiley JS; Juneja S; Wierda WG; Green AR; Keating MJ; Christopherson RI
    Br J Haematol; 2006 Oct; 135(2):184-97. PubMed ID: 16939496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of B-chronic lymphocytic leukemia and acute myeloid leukemia.
    Carulli G; Marini A; Baccelli E; Lambelet P; Lari T; Azzarà A
    J Exp Clin Cancer Res; 2007 Sep; 26(3):421-4. PubMed ID: 17987806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Leukemic immunophenotyping with flow cytometry].
    Takase K
    Rinsho Ketsueki; 1990 Jun; 31(6):720-8. PubMed ID: 2214163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The diagnostic significance of blast immunophenotype assay in patients with acute leukemia].
    Piatoska-Jakubas B; Pituch-Noworolska A; Skotnicki AB; Balana-Nowak A
    Acta Haematol Pol; 1996; 27(1):33-41. PubMed ID: 8629441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J; Cáp J; Gyárfás J; Koubek K
    Neoplasma; 1998; 45(3):128-34. PubMed ID: 9717523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Monoclonal antibodies in diagnosis of acute leukemias].
    Krawczyńska A; Robak T
    Przegl Lek; 1996; 53(1):20-5. PubMed ID: 8711170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
    Crisan D; David D; DiCarlo R
    Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
    Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. WT1 protein expression in childhood acute leukemia.
    Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
    Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory practices in reporting flow cytometry phenotyping results for leukemia/lymphoma specimens: results of a survey.
    Hassett J; Parker J
    Cytometry; 1995 Dec; 22(4):264-81; discussion 330. PubMed ID: 8749777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
    Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
    Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunophenotypic diagnosis of acute leukemia by using decision tree induction.
    Cualing H; Kothari R; Balachander T
    Lab Invest; 1999 Feb; 79(2):205-12. PubMed ID: 10068208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
    Larson RS; McCurley TL
    Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.
    Cruse JM; Lewis RE; Pierce S; Lam J; Tadros Y
    Exp Mol Pathol; 2005 Aug; 79(1):39-41. PubMed ID: 16005710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of CDw12 and CD17 cell surface antigens on leukemic cells from patients with blood malignancies.
    Marinov J; Koubek K; Starý J
    Folia Biol (Praha); 1993; 39(3):124-8. PubMed ID: 8157132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modern diagnostics in acute leukemias.
    Haferlach T; Kern W; Schnittger S; Schoch C
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
    Meyerson HJ; Blidaru G; Edinger A; Osei E; Schweitzer K; Fu P; Ho L
    Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
    Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.